Lifeward Ltd. (LFWD) vs Medicus Pharma Ltd. Common Stock (MDCX)
A side-by-side comparison of Lifeward Ltd. and Medicus Pharma Ltd. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LFWD
Lifeward Ltd.
$6.27HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — LFWD vs MDCX
growth of $100 · dividends reinvested · last 2yLFWD -72.2% (-47.3%/yr)MDCX -93.7% (-74.9%/yr)LFWD compounded faster over this window
LFWD MDCX
LFWD vs MDCX: by the numbers
- •MDCX is the larger company ($10M vs $10M market cap).
- •Both run net losses; MDCX's is the smaller (0.00% vs -141.28% net margin).
Metrics side by side
Valuation
| Metric | LFWD | MDCX |
|---|---|---|
| P/S ratio | 0.46 | N/A |
| P/B ratio | 0.83 | N/A |
Profitability
| Metric | LFWD | MDCX |
|---|---|---|
| Gross margin | 35.95% | 0.00% |
| Operating margin | -76.66% | 0.00% |
| Net margin | -141.28% | 0.00% |
| ROE | -252.37% | N/A |
| ROIC | -95.42% | -269.16% |
Growth (annualized)
| Metric | LFWD | MDCX |
|---|---|---|
| Revenue CAGR (5Y) | 38.07% | N/A |
| Total return CAGR (5Y) | -43.18% | N/A |
Go deeper
Dig into the metrics
Lifeward ROEMedicus Pharma Ltd. Common Stock ROELifeward operating marginMedicus Pharma Ltd. Common Stock operating marginLifeward revenue growthMedicus Pharma Ltd. Common Stock revenue growthLifeward free cash flowMedicus Pharma Ltd. Common Stock free cash flow
Lifeward & Medicus Pharma Ltd. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.